ORIGINAL RESEARCH article

Front. Immunol.

Sec. Microbial Immunology

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1613002

This article is part of the Research TopicImmune-gut-brain axis - A Key Player in Overall Human PathologiesView all articles

T he level of I-FABP and IgA/IgG to beta-lactoglobulin in mothers at risk for gestational diabetes and in their children: association with antibodies to Bifidobacterium adolescentis and Bifidobacterium breve

Provisionally accepted
Tamara  VorobjovaTamara Vorobjova1,2*Aili  TagomaAili Tagoma2Celeste  PetersonCeleste Peterson2Ija  TaljaIja Talja2Anu  BärensonAnu Bärenson3Kristi  AlnekKristi Alnek2Helis  JansonHelis Janson2Kaja  MetskülaKaja Metsküla2Anne  KirssAnne Kirss4Epp  SeppEpp Sepp5Tiiu  RööpTiiu Rööp5Siiri  KõljalgSiiri Kõljalg5Raivo  UiboRaivo Uibo2
  • 1University of Tartu, Tartu, Estonia
  • 2Department of Immunology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia
  • 3Department of Pediatrics, University of Tartu. Children's Clinic of Tartu University Hospital, Tartu, Estonia
  • 4Women's Clinic, Tartu University Hospital, Tartu, Tartu County, Estonia
  • 5Department of Microbiology, Institute of Biomedicine and Traslational Medicine, University of Tartu, Tartu, Estonia

The final, formatted version of the article will be published soon.

Background: The mechanisms underlying gestational diabetes mellitus (GDM) and their impact on maternal and child immunity remain unclear. We hypothesize that gut microbiome alterations and increased small intestinal permeability contribute to GDM. Intestinal fatty acid-binding protein (I-FABP) leakage and elevated IgA/IgG against beta-lactoglobulin may indicate mucosal damage and may serve as biomarkers.Methods: This study evaluated I-FABP and IgA/IgG levels against beta-lactoglobulin in mothers with and without GDM (n=100) and in their children (n=87 at time point 1 (TP1), n=79 at time point 2 (TP2). Levels of antibody to Bifidobacterium adolescentis (DSM20083, DSM20086) and Bifidobacterium breve (DSM20213) were assessed using flow cytometry. I-FABP was measured using the Hycult Biotech ELISA Kit, and IgA/IgG levels to beta-lactoglobulin were measured using in-house ELISA.Results: I-FABP and IgA/IgG levels did not significantly differ between mothers with and without GDM. However, children at TP1 had significantly higher I-FABP, IgA and IgG levels to beta-lactoglobulin than their mothers (p<0.01). In children, both I-FABP and IgA levels to beta-lactoglobulin declined with age (p<0.05). The children of mothers with GDM had higher IgA levels to beta-lactoglobulin (p=0.004). I-FABP was inversely correlated with IgA to B. adolescentis in GDM mothers (p<0.002). Breastfeed children had higher beta-lactoglobulin IgA/IgG levels (p=0.02), but I-FABP levels did not differ regarding the length of breastfeeding.Conclusion: Higher I-FABP and IgA levels to beta-lactoglobulin in children suggest increased intestinal permeability compared to adults. Only IgA to beta-lactoglobulin was significantly elevated in the children of mothers with GDM.

Keywords: gestational diabetes mellitus, I-FABP, IgA and IgG to beta-lactoglobulin, IgA and IgG to Bifidobacterium, ELISA, immunoblot, flow cytometry Font: Italic Font: Italic Formatted: Font: Italic Formatted: Font: Italic Formatted: Font: Italic Deleted: Jul; Formatted: Font: Italic

Received: 16 Apr 2025; Accepted: 11 Jun 2025.

Copyright: © 2025 Vorobjova, Tagoma, Peterson, Talja, Bärenson, Alnek, Janson, Metsküla, Kirss, Sepp, Rööp, Kõljalg and Uibo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Tamara Vorobjova, University of Tartu, Tartu, Estonia

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.